Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD. by Thulborn, S, Dilpazir, M, Haldar, K, Mistry, V, Brightling, C, Barer, M, Bafadhel, M

Late breaking abstract - Resistomics of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of antimicrobial-resistance-encoding genes by Ramsheh, M, Haldar, K, Bafadhel, M, Mistry, V, Goerge, L, Oggioni, M, Barer, M, Brightling, C

Sputum microbiomic clustering in asthma and COPD reveals a Haemophilus‐predominant subgroup by Diver, S, Richardson, M, Haldar, K, Ghebre, M, Ramsheh, M, Bafadhel, M, Desai, D, Cohen, E, Newbold, P, Rapley, L, Rugman, P, Pavord, I, May, R, Barer, M, Brightling, C

Biological exacerbation clusters demonstrate asthma and COPD overlap with distinct mediator and microbiome profiles by Ghebre, M, Pang, P, Diver, S, Desai, D, Bafadhel, M, Haldar, K, Kebadze, T, Cohen, S, Newbold, P, Rapley, L, Woods, J, Rugman, P, Pavord, I, Johnston, S, Barer, M, May, R, Brightling, C

A dose escalation study to evaluate the safety of an aerosol BCG infection in previously BCG-vaccinated healthy human UK adults by Fredsgaard-Jones, T, Harris, SA, Morrison, H, Ateere, A, Nassanga, B, Ramon, RL, Mitton, C, Fletcher, E, Decker, J, Preston-Jones, H, Jackson, S, Mawer, A, Satti, I, Barer, M, Hinks, T, Bettinson, H, McShane, H